Skye Bioscience, Inc. (SKYE) stock
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00−0.06 (-6.10%)
Close on Nov 17, 2026Market cap $35.42MP/E –Yield –
Skye Bioscience pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Skye Bioscience's pe ratio was 5.5× on Jul 31, 2020.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Jul 31, 2020 | 5.5× | – |
See a number that looks wrong?